Literature DB >> 1476470

Mansonella perstans filariasis: failure of albendazole treatment.

E Van den Enden1, A Van Gompel, T Vervoort, P Van der Stuyft, J Van den Ende.   

Abstract

Infections with Mansonella perstans are common in certain parts of Africa and South America. There is no standard treatment at present. We evaluated the effect of albendazole on microfilaremia in ten consecutive patients. No decrease in microfilarial counts could be demonstrated after a median follow-up period of 45 days. Albendazole was not shown to be useful for treatment of Mansonella perstans filariasis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1476470

Source DB:  PubMed          Journal:  Ann Soc Belg Med Trop        ISSN: 0772-4128


  3 in total

1.  Molecular identification of Wolbachia from the filarial nematode Mansonella perstans.

Authors:  Paul B Keiser; Yaya Coulibaly; Joseph Kubofcik; Abdallah A Diallo; Amy D Klion; Sekou F Traoré; Thomas B Nutman
Journal:  Mol Biochem Parasitol       Date:  2008-05-02       Impact factor: 1.759

Review 2.  Mansonellosis: current perspectives.

Authors:  Thuy-Huong Ta-Tang; James L Crainey; Rory J Post; Sergio Lb Luz; José M Rubio
Journal:  Res Rep Trop Med       Date:  2018-01-18

3.  Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update.

Authors:  Jong-Yil Chai; Bong-Kwang Jung; Sung-Jong Hong
Journal:  Korean J Parasitol       Date:  2021-06-21       Impact factor: 1.341

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.